Elanco Animal Health Incorporated (ELAN) |
| 22.56 -0.36 (-1.57%) 10-12 16:00 |
| Open: | 22.85 |
| High: | 22.9 |
| Low: | 22.55 |
| Volume: | 4,652,937 |
| Market Cap: | 11,268(M) |
| PE Ratio: | 21.28 |
| Exchange: | New York Stock Exchange |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 24.38 |
| Resistance 1: | 23.33 |
| Pivot price: | 22.46 |
| Support 1: | 21.62 |
| Support 2: | 17.99 |
| 52w High: | 27.98 |
| 52w Low: | 19.4 |
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
| EPS | -0.410 |
| Book Value | 13.190 |
| PEG Ratio | 4.04 |
| Gross Profit | 5.566 |
| Profit Margin (%) | -3.96 |
| Operating Margin (%) | 8.63 |
| Return on Assets (ttm) | 1.6 |
| Return on Equity (ttm) | -3.0 |
Sat, 10 Oct 2026
Elanco Animal Health Incorporated (ELAN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fri, 09 Oct 2026
Elanco Animal Health Incorporated (ELAN) stock price, news, quote and history - Yahoo Finance UK
Thu, 08 Oct 2026
Elanco Animal Health Incorporated (ELAN) Stock Price, News & Analysis - Stock Titan
Wed, 07 Oct 2026
One Health Innovation District Breaks Ground on One Health Research Institute, Anchored by Purdue University and Elanco Animal Health - CSRwire
Tue, 06 Oct 2026
An executive at Elanco (ELAN) acquires 66.7087 stock-linked units at $22.14 each. - Stock Titan
Tue, 06 Oct 2026
At $22.14 each, Elanco (ELAN) CFO acquires 8.8988 units payable in shares or cash. - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |